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A total of 165 patients underwent CAG -151 conventional and 14 CT CAG. Thirty-four patients had undergone coronary revascularization in the past 5 years and asymptomatic for the same [ Figure 1 ]. The CAG findings were divided into five groups for risk stratification -normal CAG, mild/minor disease (minor plaques and stenosis <50%), significant single-vessel disease >50%, double-vessel disease (DVD), and triple-vessel disease (TVD) [ Table 1 ]. [4, 5] The overall incidence of significant CAD with critical single-vessel disease/DVD/ TVD was seen in 105 patients (52.7%). About 40 patients in this group underwent either PCI or coronary artery bypass grafting (CABG) before aneurysm surgery (36 underwent PCI and 4 underwent CABG), while 65 underwent surgery without prior revascularization.
Three patients (out of 4) underwent concomitant CABG with aneurysm repair. One patient underwent off-pump CABG, whereas others underwent on-pump CABG. In this subset, CABG was performed first, followed by aneurysm repair.
A total of 19 patients had cardiac morbidity in the immediate postoperative period in the form of arrhythmias, non-ST-segment elevation myocardial infarction, and cardiac failure but AAA patients remains limited. The purpose of this study was to assess the incidence of CAD and PAD in patients undergoing elective AAA repair. This was a single-center retrospective study. Patients who underwent emergency repair of ruptured aortic aneurysm, suprarenal aneurysms, and those who underwent EVAR were excluded from the study. Patients who underwent aortic revascularization procedure (incidental aortic aneurysm with iliofemoral occlusion) were also not included in the study as they were considered as transatlantic inter-society consensus D (TASC-D) aortoiliac disease.
PATiEnTS And METHOdS
All the patients underwent preoperative coronary angiogram (CAG) either conventional or computed tomography (CT) CAG as an institutional protocol, except if they already had a history of CAD and underwent prior intervention in the past 5 years and were asymptomatic. [3] Perioperative adverse cardiac event was defined as elevated cardiac biomarkers [4] (Troponin T and PAD was identified as the presence of lower limb arterial disease, which was incidentally detected and whether the patient was symptomatic in the form of claudication or critical limb ischemia based on the Ankle-Brachial Pressure Index (ABI <0.9) and tissue loss.
Data were collected from the patient's hospital records and electronic medical records. Statistical analysis was done using the Chi-square test, log-rank test, and Kaplan-Meyer survival analysis. All data analysis was done using SPSS-16 statistical analysis software.
RESULTS
The were successfully managed conservatively; 2 out of 19 had undergone concomitant CABG, 1 had undergone preoperative PCI, and 16 had not undergone coronary revascularization. Four patients died in the perioperative period with one dying of cardiac cause, while four patients had long-term mortality due to cardiac causes. The overall mortality was 18 (9%) in the study group [ Table 2 ].
Twenty-six patients (13.1%) had PAD of varying degrees of severity. Eleven out of these 26 patients were having mild intermittent claudication with infrapopliteal arterial disease. Nine patients had disabling claudication (ABI 0.5-0.8). Six patients had incidentally detected PAD and were not symptomatic. Five patients had atheroembolism in the postoperative period with cyanosis of toes and were successfully managed with anticoagulation (up to 3 months) alone. All 5 patients had complete disappearance of symptoms by 3-4 weeks. We noticed that 16 of 26 patients (all 9 in disabling claudication group and 7 in mild claudication) had significant improvement in their symptoms during follow-up [ Figure 2 ].
diScUSSiOn
Open repair has stood the test of time and is considered the gold standard for the treatment of AAA. The open surgery has come a long way with excellent survival rates owing to better pre-and peri-operative optimization of patients. The perioperative morbidity and long-term mortality of open aortic aneurysm surgery are still accounted by cardiac causes. This was the basis for subjecting patients to routine preoperative coronary imaging with or without revascularization, which is still a matter of debate. [5, 6] One of the earliest studies was done by Hertzer et al. retrospectively in 1522 patients, where he found that 81% of the patients with postoperative MI or cardiac death had at least one total coronary artery occlusion with collaterals compared with 29% in match-controlled patients without cardiac complications. [5] In every other respect, patients with postoperative complications also had more severe CAD prior to surgery as compared with the control group. In their cohort, 68% of preoperative patients had minimal or no clinically significant angiographic findings (<70% disease). Among patients with significant coronary stenosis, there was a spectrum of single-(46%), double-(33%), and triple (21%)-vessel diseases. [3] Our study cohort also had a high incidence of clinically significant CAD (52.7%).
Similarly, Suggs et al. found that among the 247 AAA repairs performed, there were three perioperative deaths (1.2%), all of which resulted from sudden cardiac events; three additional patients had nonfatal myocardial infarctions (1.2%), for a total cardiac complication rate of 2.4%. [7] The low rate of cardiac complications in this experience affirms the effectiveness of preoperative screening and selective coronary revascularization before AAA repair. In this study, one patient who died in the perioperative period had severe CAD, but surgery was performed without prior revascularization as he was symptomatic with large aneurysm size.
As a matter of protocol, our institution routinely performs conventional or CT CAG for all patients undergoing elective aortic aneurysm repair surgery. Those patients who have a history of CAD and underwent CABG/PCI in the last 5 years, with no evidence of myocardial insufficiency will not undergo further coronary imaging as per the findings in the Coronary Artery Revascularization Prophylaxis (CARP) trial and the American College of Cardiology recommendations. [6] However, the limitations of CARP trial were striking in that only a minority of the patients had evidence of severe ischemia on noninvasive testing, and the study was underpowered to assess this key aspect. It also excluded significant left anterior descending artery disease and severe LV dysfunction. Later, studies based on CARP and registry data, however, revealed that the long-term survival benefit was achieved with preoperative coronary revascularization. [8, 7] Monaco et al. with systematic strategy discovered 50% more patients with significant CAD than the selective strategy and had more subsequent coronary revascularizations (58% vs. 40%, respectively) and was associated with significantly better long-term survival and freedom from major adverse cardiac events. [8] Mangano et al. found that in high-risk patients undergoing noncardiac surgery, early postoperative myocardial ischemia is an important correlate of adverse cardiac outcomes. [9] Sixteen out of 19 patients had postoperative cardiac morbidity although not fatal. Ruddy et al. found that either staged or concomitant CABG and AAA repair may be viable options when minimally invasive interventions are not feasible. [10] In light of this, it is of no debate that, preoperative coronary imaging definitely aids in proper risk stratification and anticipation of possible perioperative cardiac events.
Even less commonly performed is concomitant CABG with AAA repair. We performed simultaneous CABG and AAA repair in three patients while one patient underwent AAA repair after 1 month of CABG. Long-term survival of these patients is awaited. Ascione et al. published their experience with the same and has been documented to be safe. [11] Takahashi et al. did a study similar to ours with similar sample size and found that the incidence of patients who required CABG in the treatment of AAA was 4.4% and that the results may justify the routine enforcement of preoperative CAG in patients with AAA. [12] The studies pertaining to the prevalence of PAD in AAA are limited, although it is an entity that is overlooked or masked due to the more serious coexisting aneurysm. Leong et al. found that there was a significant association of PAD and AAA in patients admitted with acute coronary syndrome. We found that majority of the patients had symptomatic relief of PAD postaneurysm repair, although they need to be followed up routinely. [13] cOncLUSiOn Based on our results, we suggest that it is worthwhile to perform routine coronary imaging for optimal risk stratification prior to surgery, and revascularization should be performed based on individual patient characteristics to prevent adverse cardiac events. We also found that, if facilities permit, concomitant CABG with AAA repair is a novel technique that can be safely performed in fit patients in whom PCI is not feasible. The presence of PAD should be identified and documented promptly in these patients with close follow-up.
